FAKTOR-ZERTIFIKAT - BIOGEN IDEC | Market Closed - Börse Stuttgart 03:49:47 2024-05-24 pm EDT | ||
| 5.02 EUR | +1.21% |
|
| Current month | -23.24% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 5.02 | +1.21% |
| 24-05-23 | 4.96 | +15.89% |
| 24-05-22 | 4.28 | +8.63% |
| 24-05-21 | 3.94 | +8.24% |
| 24-05-20 | 3.64 | -2.67% |
Delayed Quote Börse Stuttgart
Last update May 24, 2024 at 03:49 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | J.P. Morgan |
| WKN | JK7Z4W |
| ISIN | DE000JK7Z4W4 |
| Date issued | 2024-04-26 |
| Strike | 254.4 $ |
| Maturity | Unlimited |
| Parity | 7.01 : 1 |
| Emission price | 10.03 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 10.02 € |
|---|---|
| Lowest since issue | 3.26 € |
| Spread | 0.3 € |
| Spread % | 5.65% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
217.8
USD
Average target price
286.1
USD
Spread / Average Target
+31.33%
- Stock Market
- Certificates
- Certificat
